September 2016 Volume 12, Issue 9
Volume 12, Issue 9 | September 2016
September 2016
In this Issue
Q&A

Q&A: Checking in with the new MilliporeSigma
DDNews discusses with Klaus-Reinhard Bischoff how things are going since Merck KGaA acquired Sigma-Aldrich in 2015 and combined it with EMD MilliporeFeature

Show Preview: CPhI Worldwide--What to expect from CPhI Worldwide this fall
The pharma community will gather to showcase services, latest research and debate key industry issues in Barcelona, Spain
Show Preview: ASHG 2016--Digging into the genome in Canada
The American Society of Human Genetics brings its annual meeting to Vancouver, with plenty new to offer, as well as the familiar and traditional
Special Focus: Recruiting the body in the war against cancer
DDNews checks in on the growing and promising activity around immuno-oncologyEditor's Focus

Knowledge gaps and mistakes, and how both can lead to better things
Let's try to cut down on the hyperbole, learn better from our mistakes and accidents and find where we can cut down on unnecessary gaps in our knowledgeCommentary

Out of order: I am not an animal
Companies may need to share preclinical data with investors, the trade press and the like, but perhaps sharing a lot less of that early-stage data with the general public would be a good idea
Guest commentary: Direct-to-consumer genetic testing--Helpful or harmful?
Personalized or precision medicine is the future for many complex diseases, but simply giving a patient knowledge of their genetic predisposition to a disease is not enoughResearch & Development

Keeping genetics straight in cancer cells
Agilent CGH platform helps assure quality of cancer cell lines
Biological circuit design gets complex
New approach in cell programming enables scientists to track cell histories
JTX-2011, the driving force
Jounce join hands with Celgene to develop next-generation immuno-oncology therapies
HCV vaccine potential?
Stem cell research reveals umbilical cord stem cells can block HCV infection
New nanoscale tech could revolutionize microscopes and study of disease
University of Missouri researchers recently published a study outlining a new, relatively inexpensive imaging platform that enables single-molecule imaging
BC Platforms to partner with Codigo46
Deal will support the creation of the largest biobank in Latin AmericaDiagnostics

Boosting breast cancer diagnostics
Study teams up protein biomarkers to increase accuracy of early breast cancer detection
TTP unveils new instrument development service
Service aimed at moving assays to market-ready products for rapidly delivering ‘sample to answer’
Better outcomes through liquid biopsy
Genomic Health and Epic collaborate to deliver prognostic biomarker for metastatic prostate cancer
Lab-on-a-chip advancement
IBM unveils new technology that allows for the sorting of smaller particles than ever
Tox prognostication
Crowdsourced scientific challenge supports predictive power of computational biology for toxicologyClinical Trials

Endpoint met for rare lung disease agent
Phase 2 results promising for Kamada’s inhaled alpha-1 antitrypsin for treatment of AATD
Skin disease solution
Abeona engages in partnership for EB gene therapy treatments
Wearable tech for trials
Medidata, Memorial Sloan Kettering Cancer Center to use mHealth wearable activity trackers in clinical trials
On to Phase 3 for PLX-PAD
Pluristem will be using a recent $8M grant for a pivotal trial in critical limb ischemia
An eye on white blood cells in black patients
Georgetown Lombardi begins first clinical trial to test palbociclib on African-American patientsDiscovery

Cross-country collaboration
Regeneron links up with Adicet for next-gen immune cell therapeutics
Crowdsourcing lung biology
A group effort on lung disease leads to new biological network model
A new target for NASH treatment
BioLineRx inks deal with Hadasit for immune system approach to treating liver disease
Seres models the gut
Company teams with Emulate Inc. on microbiome therapeutics for IBD and other serious conditions
On the cutting edge
A roundup of instrumentation, software and other tools and technology newsBusiness & Government Policy

A first for Fast Track designation
Caladrius’ CLBS03 is first experimental therapeutic for type 1 diabetes to get such designation
Going after growth
Agile aiming to expand contraceptive pipeline with new regimen
Mylan draws heat around EpiPen cost
Controversy is bringing about a call for potential regulatory changes
Preventing disparities in gene-based therapeutics and diagnostics
For all their promise, genetically based therapeutics and diagnostics still fall short of being representative of—and applicable to—the population as a wholePreclinical

FibroStatin’s T12 ready to deliver TKO?
Lead candidate proves effective in fight vs. drug-resistant invasive cancer, organ fibrosis
ArQule presents preclinical data for ARQ 531
Data supports further preclinical and clinical research in BTK-sensitive and ibrutinib-resistant malignancies
Transformative transaction
Chronos acquires preclinical programs from Shire to expand pipeline
Getting into the liver with CRISPR
Data from Intellia show continued progress in in-vivo gene editing with systemic lipid nanoparticle delivery
Anti-malaria drug could make tumors easier to treat
A recent study looked at the effect of atovaquone on tumors with low oxygen levels in mice
MR Solutions offers choice of two preclinical cryogen- free MRI scanner ranges
MR Solutions is now offering a choice of two cryogen-free preclinical scanner ranges: the Flexiscan and PowerscanContract Services

Promising opportunities
Private equity fund targets life-sciences and healthcare services, starting with CRO
If you build it, they will come
Vetter to invest $320 million in manufacturing plant
Recent recognition
A collection of some CROs lauded within the industry

Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe